(TheNewswire)
Vancouver, BC -- TheNewswire - October 14, 2020 - Vodis Pharmaceuticals Inc (CSE:VP) (CNSX:VP.CN) (OTC:VDQSF),(" Vodis ") is pleased to announce apackaging, processing, and distribution agreement between VodisInnovative Pharmaceuticals, its wholly owned subsidiary under itsGnomestar premium craft cannabis brand, and BCCraft Supply Co. Ltd. ( " BC Craft ") .
Gnomestar presents an exciting BC cultivar into the theBC Craft supply chain; a rare and evenly balanced hybrid cannabisstrain called Meat Breath. Vodis' first go-to-market crop has beenpurchased by BC Craft and shipped to Indiva Limited("Indiva") (TSXV:NDVA)(OTCQX: NDVAF ) for processing under a masterprocessing agreement ("MPA") that was announced on May13, 2020 . Under the MPA,the dried flower will be processed and packagedinto Indiva's new premium brand, Artisan Batch, in beautiful 3.5 gramjars. Artisan Batch features strains from craft and micro growersacross Canada, who pride themselves on the quality, potency, andterpene profile of their strains.
Vodis Pharmaceuticals Inc. is a licensed cannabisproducer and processor located in Delta, BC. Their brand is GnomestarCraft Cannabis and all dried flower products are hand-harvested, hangdried, and hand trimmed for the most discerning cannabis consumer. Mark Lotz, CEO states, "The relationship with BC Craft marks aturning point for Vodis - our first sale of product. Our entire teamis extremely proud of this accomplishment. We are grateful to bepartnered with BC Craft and we hope customers appreciate the amount ofcare that goes into the cultivation of our flower." Mr. Picken,our head grower who painstakingly tended and oversaw every aspect,added, "No detail has been overlooked to ensure the consumer getsthe best product possible. Adapting to the needs of the plant atevery stage of its life-cycle, is the key to getting the utmost fromthe carefull selected genetics." Meat Breath is a trulyeye-catching cannabis strain and with Vodis'-testing at over 23.8% THC and 2.7% terpene profile, it's sure to leavea lasting impression in today's legal market.
Matthew Watters, CEO of BC Craft further stated,"The Vodis team have cultivated a beautiful high end artisanaldried flower that connoisseurs of high end cannabis are sure to enjoyin the Canadian recreational market and we can not wait until they areavailable on store shelves shortly."
About Gnomestar
Gnomestar is a brand of Vodis InnovativePharmaceuticals, a wholly-owned subsidiary of Vodis Pharmaceuticals(CSE:VP), located in Delta BC whose facility is specifically designedfor small batch cannabis production. The growing team evolved from theearly stages of the MMAR to now being a federally licensed cannabisproducer processor under the Canadian Cannabis Act. Our mandate is toprovide the best cannabis experience to our customers through rigorousquality control measures and a team that has decades of experience incannabis. www.vodis.ca
CONTACT
Mark Lotz
Director
Phone: 604-880-6546
Email: mark@Vodis.ca
DISCLAIMER AND READER ADVISORY
Neither the Canadian SecuritiesExchange nor its Regulation Services Provider (as that term is definedin the policies of the Canadian Securities Exchange) acceptsresponsibility for the adequacy or accuracy of this press release,which has been prepared by management.
This news release includes certain"forward-looking statements" under applicable Canadiansecurities legislation. Forward-looking statements are necessarilybased upon a number of estimates and assumptions that, whileconsidered reasonable, are subject to known and unknown risks,uncertainties, and other factors which may cause the actual resultsand future events to differ materially from those expressed or impliedby such forward-looking statements. There can be no assurance that such statements will proveto be accurate, as actual results and future events could differmaterially from those anticipated in such statements. Accordingly,readers should not place undue reliance on forward-looking statements.Pasha disclaims any intention or obligation to update or revise anyforward-looking statements, whether as a result of new information,future events or otherwise, except as required by law.
Copyright (c) 2020 TheNewswire - All rights reserved.